全球微阵列市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球微阵列市场 – 行业趋势及 2029 年预测

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Microarray Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 3,407.66 Million
Diagram Market Size (Forecast Year)
USD 8,995.40 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球微阵列市场,按产品(消耗品、软件、仪器)、类型(DNA、蛋白质、其他)、应用(研究、药物发现、疾病诊断)、最终用户(研究和学术机构、制药和生物技术公司、诊断实验室、其他)划分——行业趋势和预测到 2029 年。

微阵列市场

全球微阵列市场分析及规模

近年来,微阵列在病毒和遗传疾病诊断、药物开发、药物基因组学研究、癌症诊断和法医应用中越来越受欢迎。因此,各种增长决定因素的存在导致市场在预测期内大幅增长。

  • 2021 年全球微阵列市场价值为 34.0766 亿美元,预计到 2029 年将达到 89.954 亿美元,2022-2029 年复合年增长率为 12.90%。Data Bridge 市场研究团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

全球微阵列市场定义

微阵列是一种尖端的分子生物学技术,用于同时检测许多基因的表达。检测设计快速、准确、经济高效且简单。微阵列可用于研究各种微分子,包括 DNA、RNA、蛋白质、酶、碳水化合物和组织。基因表达谱、分子相互作用、生物标志物谱、酶活性、通路识别和突变都是可能的应用。微阵列正用于临床研究和诊断以及基础研究。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2014)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按产品(消耗品、软件、仪器)、类型(DNA、蛋白质、其他)、应用(研究、药物研发、疾病诊断)、最终用户(研究和学术机构、制药和生物技术公司、诊断实验室、其他)

覆盖国家

美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区

涵盖的市场参与者

Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Molecular Devices, LLC (U.S.), PerkinElmer Inc. (U.S.), EKF Diagnostics (UK), Illumina, Inc. (U.S.), General Electric (U.S.), and Bio-Rad Laboratories Inc. (U.S.), bioMérieux (France), BD (U.S.). Danaher (U.S.), Biosystems Inc., (U.S.),  Luminex Corporation (U.S.),  F. Hoffmann-La Roche Ltd., (Switzerland), Merck KGaA (Germany) and Danaher (U.S.)

Market Opportunities

  • Increase in the funding for genomic and proteomic research
  • Rising need for research in the pharmaceutical as well as healthcare industry
  • Advancement of diagnosis and treatment options

Microarray Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Growing Burden Of Diseases

The high frequency of cancer and the rising prevalence of various chronic diseases as well as the utilization of this approach to identify infectious diseases are driving the market forward. This is the most significant factor driving the growth for this market.

  • High Usage for Various Applications

The usage of microarrays for numerous applications such as genotyping, forensic analysis, measuring predisposition to disease, evaluating somatic mutations in cancers or germline mutations in individuals, assessing loss of heterozygosity, among others are also expected to accelerate the overall growth of the market.

Furthermore, the expanding healthcare sector, increase in government funding for the healthcare sector, and the development in genetics are also expected to fuel market growth within the forecasted period. The rapidly evolving information and software technology as well as emerging bioinformatics, are also projected to bolster the growth of the market.

Opportunities

  • Growing Advancements in Treatment

The advancement of diagnosis and treatment options has resulted in the development of goods that can assist patients in a wide range of situations, further offering numerous growth opportunities for the market.

  • Surging Research and Funding Activities

There has been an increase in healthcare research and development, as there is a rising need for research in the pharmaceutical and healthcare industry. Therefore, the increase in genomic and proteomic research funding is also estimated to generate lucrative opportunities for the market.

Restraints/Challenges Global Microarray Market

  • Requirement Of High-Tech Instruments 

On the other hand, the microarray basically requires high-tech instruments, which are very costly. Additionally, the cost of tests is also very high, which is expected to obstruct market growth.

  • Availability of Substitutes

The availability of substitutes and the presence of alternate mediums for the analysis are estimated to impede the market's overall growth.

Also, the need for standardization of databases along with the shortage of skilled professionals are projected to challenge the microarray market in the forecast period of 2022-2029.

This microarray market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microarray market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Microarray Market

The microarray market was positively impacted by the outbreak of COVID-19. The rise in cases around the world has largely increased the vaccine research and development during Covid-19. As a result, prominent firms have launched a slew of new products to test immune surveillance, diagnostics, and vaccines. JPT Peptide Technologies (JPT) launched a set of ready-to-use peptide tools in April 2020 to analyze and profile the immune response to SARS-CoV-2 infection. The UC Irvine Vaccine R&D Center has also created a mechanism to evaluate COVID-19 protection against 34 coronavirus antigens, or 33 antigens. However, the disruption of the supply chain has made it difficult for microarray providers to obtain prepared microarray in time to fulfill the rising demand of populations. The research institution's routine operations have been delayed due to the lockdown. But the rising demand for testing and research is expected to rise as microarray technology becomes more widely used and as the number of patients suffering from various diseases rises, which will push the market's growth on a large scale.

Recent Developments

  • In June 2020, Thermo Fisher Scientific launched the Axiom Human Genotyping SARS-CoV-2 Research Array, which will help epidemiologists to study the SARS-CoV-2 infectious disease.
  • In April 2020, Celsee, Inc., a firm that provides instruments and consumables for the separation, detection, and analysis of single cells, has been bought by Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products. The acquisition's terms were not disclosed. During Bio-first-quarter Rad's 2020 financial results conference call, the company will go over the purchase in greater detail.

Global Microarray Market Scope

微阵列市场根据产品、类型、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

产品

  • 耗材
  • 软件
  • 仪器

根据产品,微阵列市场分为消耗品、软件和仪器。

类型

  • 脱氧核糖核酸
  • 蛋白质
  • 其他

根据类型,微阵列市场分为 DNA、蛋白质和其他。

应用

  • 研究
  • 药物研发
  • 疾病诊断

根据应用,微阵列市场分为研究、药物发现和疾病诊断。

最终用户

  • 研究与学术机构
  • 制药和生物技术公司
  • 诊断实验室
  • 其他的

根据最终用户,微阵列市场分为研究和学术机构、制药和生物技术公司、诊断实验室和其他。

微阵列市场区域分析/见解

对微阵列市场进行了分析,并按国家、产品、类型、应用和最终用户提供了市场规模的见解和趋势。

微阵列市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美在微阵列市场占据主导地位,因为该地区癌症和遗传病等各种疾病的发病率不断增加,加之基因组学和蛋白质组学研究的资金不断增加。

由于政府对医疗保健行业的资助增加、老年人口不断增长以及该地区慢性病和癌症发病率不断上升,预计亚太地区在 2022 年至 2029 年的预测期内将出现显著增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

微阵列市场还为您提供每个国家/地区资本设备医疗保健支出增长、微阵列市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对微阵列市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和微阵列市场份额分析

微阵列市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对微阵列市场的关注有关。

微阵列市场的一些主要参与者包括

  • 赛默飞世尔科技公司(美国)
  • 安捷伦科技公司(美国)
  • Molecular Devices, LLC(美国)
  • PerkinElmer Inc.(美国)
  • EKF 诊断(英国)
  • Illumina 公司(美国)
  • 通用电气(美国)
  • Bio-Rad Laboratories Inc.(美国)
  • 生物梅里埃(法国)
  • BD(美国)
  • 丹纳赫(美国)
  • Biosystems Inc.,(美国)
  • Luminex 公司(美国)
  • F. Hoffmann-La Roche Ltd.(瑞士)
  • 默克集团(德国)
  • 丹纳赫(美国)

研究方法:全球微阵列市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息,请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,涉及数据挖掘、数据变量对市场影响的分析以及主要(行业专家)验证。除此之外,数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-microarray-market


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Microarray Market is Expected to Show a Value of USD 8,995.4 million by 2029.
The Microarray Market is Estimated to Register a CAGR of 12.90% During the Forecast Period of 2022 to 2029.
The Major Companies Operating in the Microarray Market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Molecular Devices, LLC (U.S.), PerkinElmer Inc. (U.S.), EKF Diagnostics (UK), Illumina, Inc. (U.S.), General Electric (U.S.), and Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany) and Danaher (U.S.).
The Countries Covered in the Microarray Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Microarray Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.